Udiliv
Udiliv is a hepatoprotective medication containing Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid. It works by reducing the amount of cholesterol in the blood and helping to dissolve gallstones composed mainly of cholesterol. It also improves bile flow and protects liver cells from damage caused by toxic bile acids.
Dosage by Body Weight
The recommended dose of Udiliv depends on the patient's body weight and the condition being treated. It is generally administered at 10-15 mg/kg of body weight daily, taken with food. The daily dose may be taken as a single dose in the evening or divided into multiple doses as prescribed by a physician.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy in neonates and infants weighing less than 5 kg have not been established. Use strictly under pediatric specialist supervision.
- Body Weight
- 5-7 kg
- Dose
- 50 mg to 100 mg daily
- Frequency
- Once daily or divided into two doses
- Tracking Notes
- Calculated based on 10-15 mg/kg/day. Liquid formulations or crushed/dispersed tablets may be required for precise dosing.
- Body Weight
- 8-10 kg
- Dose
- 100 mg to 150 mg daily
- Frequency
- Once daily or divided into two doses
- Tracking Notes
- Administer with food. Monitor liver function tests regularly as advised by the doctor.
- Body Weight
- 11-15 kg
- Dose
- 150 mg to 225 mg daily
- Frequency
- Divided into 2 doses
- Tracking Notes
- Doses should be adjusted according to the target therapeutic indication (e.g., cystic fibrosis-related liver disease may require higher doses up to 20 mg/kg/day).
- Body Weight
- 16-20 kg
- Dose
- 200 mg to 300 mg daily
- Frequency
- Divided into 2 doses
- Tracking Notes
- A single Udiliv 150 mg tablet or divided parts of a 300 mg tablet may be used if the child can safely swallow solid dosage forms.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and efficacy in neonates and infants weighing less than 5 kg have not been established. Use strictly under pediatric specialist supervision. |
| 5-7 kg | 50 mg to 100 mg daily | Once daily or divided into two doses | Calculated based on 10-15 mg/kg/day. Liquid formulations or crushed/dispersed tablets may be required for precise dosing. |
| 8-10 kg | 100 mg to 150 mg daily | Once daily or divided into two doses | Administer with food. Monitor liver function tests regularly as advised by the doctor. |
| 11-15 kg | 150 mg to 225 mg daily | Divided into 2 doses | Doses should be adjusted according to the target therapeutic indication (e.g., cystic fibrosis-related liver disease may require higher doses up to 20 mg/kg/day). |
| 16-20 kg | 200 mg to 300 mg daily | Divided into 2 doses | A single Udiliv 150 mg tablet or divided parts of a 300 mg tablet may be used if the child can safely swallow solid dosage forms. |
Formulation
Purpose
Udiliv is used for dissolving cholesterol-rich gallstones, treating Primary Biliary Cholangitis (PBC), and managing various chronic cholestatic liver diseases.
Generic Name
Ursodeoxycholic AcidScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.